(Q39666421)

13 September 2017

Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours (English)

1 reference

13 September 2017

8

Jean Claude Reubi

1 reference

13 September 2017

Rosalba Mansi

1

1 reference

13 September 2017

Xuejuan Wang

2

1 reference

13 September 2017

Flavio Forrer

3

1 reference

13 September 2017

Beatrice Waser

4

1 reference

13 September 2017

Renzo Cescato

5

1 reference

13 September 2017

Keith Graham

6

1 reference

13 September 2017

Sandra Borkowski

7

1 reference

13 September 2017

Helmut R Maecke

9

1 reference

13 September 2017

18 August 2010

1 reference

13 September 2017

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

13 September 2017

38

1 reference

13 September 2017

1

1 reference

13 September 2017

97-107

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-010-1596-9

13 September 2017

0 references

cites work

Receptor targeting for tumor localisation and therapy with radiopeptides

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1596-9

Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1596-9

Comparative Study of In Vitro and In Vivo Activities of Bombesin Pseudopeptide Analogs Modified on the C-Terminal Dipeptide Fragment

21 January 2018

1 reference

12 December 2020

Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.

1 reference

12 December 2020

Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells

1 reference

12 December 2020

Candidates for peptide receptor radiotherapy today and in the future.

1 reference

12 December 2020

Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells.

1 reference

12 December 2020

Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat

1 reference

12 December 2020

Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues

1 reference

12 December 2020

Bombesin receptors in distinct tissue compartments of human pancreatic diseases

1 reference

12 December 2020

Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides

1 reference

12 December 2020

Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors

1 reference

12 December 2020

A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.

1 reference

12 December 2020

177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression

1 reference

12 December 2020

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

12 December 2020

Progress in the development of potent bombesin receptor antagonists

1 reference

12 December 2020

Localization of specific binding sites for bombesin in the canine gastrointestinal tract

1 reference

12 December 2020

Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors

1 reference

12 December 2020

Syntheses and biological activities of potent bombesin receptor antagonists

1 reference

12 December 2020

In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals.

1 reference

12 December 2020

Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers

1 reference

12 December 2020

Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression

1 reference

12 December 2020

Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity

1 reference

12 December 2020

Receptor radionuclide therapy of tumors: a road from basic research to clinical applications

1 reference

12 December 2020

NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors

1 reference

12 December 2020

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors

1 reference

12 December 2020

Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study

1 reference

12 December 2020

Bombesin receptor antagonists may be preferable to agonists for tumor targeting

1 reference

12 December 2020

Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14)

1 reference

12 December 2020

Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector

1 reference

12 December 2020

MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.

1 reference

12 December 2020

New insights in insurmountable antagonism

1 reference

12 December 2020

Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model

1 reference

12 December 2020

177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.

1 reference

12 December 2020

Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.

1 reference

12 December 2020

High expression of peptide receptors as a novel target in gastrointestinal stromal tumours

1 reference

12 December 2020

(68)Ga-labeled peptides in tumor imaging.

1 reference

12 December 2020

10.1007/S00259-010-1596-9

Identifiers

DOI

1 reference

13 September 2017

1 reference